These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 23663739)
21. Astrocytic glycogen accumulation drives the pathophysiology of neurodegeneration in Lafora disease. Duran J; Hervera A; Markussen KH; Varea O; López-Soldado I; Sun RC; Del Río JA; Gentry MS; Guinovart JJ Brain; 2021 Sep; 144(8):2349-2360. PubMed ID: 33822008 [TBL] [Abstract][Full Text] [Related]
22. Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy. Chan EM; Ackerley CA; Lohi H; Ianzano L; Cortez MA; Shannon P; Scherer SW; Minassian BA Hum Mol Genet; 2004 Jun; 13(11):1117-29. PubMed ID: 15102711 [TBL] [Abstract][Full Text] [Related]
23. Abnormal metabolism of glycogen phosphate as a cause for Lafora disease. Tagliabracci VS; Girard JM; Segvich D; Meyer C; Turnbull J; Zhao X; Minassian BA; Depaoli-Roach AA; Roach PJ J Biol Chem; 2008 Dec; 283(49):33816-25. PubMed ID: 18852261 [TBL] [Abstract][Full Text] [Related]
24. Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease. Raththagala M; Brewer MK; Parker MW; Sherwood AR; Wong BK; Hsu S; Bridges TM; Paasch BC; Hellman LM; Husodo S; Meekins DA; Taylor AO; Turner BD; Auger KD; Dukhande VV; Chakravarthy S; Sanz P; Woods VL; Li S; Vander Kooi CW; Gentry MS Mol Cell; 2015 Jan; 57(2):261-72. PubMed ID: 25544560 [TBL] [Abstract][Full Text] [Related]
25. Brain glycogen in health and disease. Duran J; Guinovart JJ Mol Aspects Med; 2015 Dec; 46():70-7. PubMed ID: 26344371 [TBL] [Abstract][Full Text] [Related]
26. Assessing the Biological Activity of the Glucan Phosphatase Laforin. Romá-Mateo C; Raththagala M; Gentry MS; Sanz P Methods Mol Biol; 2016; 1447():107-19. PubMed ID: 27514803 [TBL] [Abstract][Full Text] [Related]
27. Laforin in autophagy: a possible link between carbohydrate and protein in Lafora disease? Puri R; Ganesh S Autophagy; 2010 Nov; 6(8):1229-31. PubMed ID: 20818153 [TBL] [Abstract][Full Text] [Related]
28. An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice. Nitschke S; Chown EE; Zhao X; Gabrielian S; Petković S; Guisso DR; Perri AM; Wang P; Ahonen S; Nitschke F; Minassian BA J Biol Chem; 2021; 296():100150. PubMed ID: 33277363 [TBL] [Abstract][Full Text] [Related]
29. PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora disease. Turnbull J; DePaoli-Roach AA; Zhao X; Cortez MA; Pencea N; Tiberia E; Piliguian M; Roach PJ; Wang P; Ackerley CA; Minassian BA PLoS Genet; 2011 Apr; 7(4):e1002037. PubMed ID: 21552327 [TBL] [Abstract][Full Text] [Related]
30. Relationship between glycogen accumulation and the laforin dual specificity phosphatase. Wang W; Parker GE; Skurat AV; Raben N; DePaoli-Roach AA; Roach PJ Biochem Biophys Res Commun; 2006 Nov; 350(3):588-92. PubMed ID: 17022935 [TBL] [Abstract][Full Text] [Related]
31. Lafora disease ubiquitin ligase malin promotes proteasomal degradation of neuronatin and regulates glycogen synthesis. Sharma J; Rao SN; Shankar SK; Satishchandra P; Jana NR Neurobiol Dis; 2011 Oct; 44(1):133-41. PubMed ID: 21742036 [TBL] [Abstract][Full Text] [Related]
32. Lafora Disease: A Review of Molecular Mechanisms and Pathology. Verhalen B; Arnold S; Minassian BA Neuropediatrics; 2018 Dec; 49(6):357-362. PubMed ID: 30336494 [TBL] [Abstract][Full Text] [Related]
33. Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases. Sullivan MA; Nitschke S; Skwara EP; Wang P; Zhao X; Pan XS; Chown EE; Wang T; Perri AM; Lee JPY; Vilaplana F; Minassian BA; Nitschke F Cell Rep; 2019 Apr; 27(5):1334-1344.e6. PubMed ID: 31042462 [TBL] [Abstract][Full Text] [Related]
34. Glycogenic activity of R6, a protein phosphatase 1 regulatory subunit, is modulated by the laforin-malin complex. Rubio-Villena C; Garcia-Gimeno MA; Sanz P Int J Biochem Cell Biol; 2013 Jul; 45(7):1479-88. PubMed ID: 23624058 [TBL] [Abstract][Full Text] [Related]
35. Targeting Gys1 with AAV-SaCas9 Decreases Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models. Gumusgoz E; Guisso DR; Kasiri S; Wu J; Dear M; Verhalen B; Nitschke S; Mitra S; Nitschke F; Minassian BA Neurotherapeutics; 2021 Apr; 18(2):1414-1425. PubMed ID: 33830476 [TBL] [Abstract][Full Text] [Related]